-
March 30, 2023
Virtual
In recognition of World Bipolar Day, NIMH experts conducted a Facebook Live event on bipolar disorder in adults.
-
February 14, 2023
Virtual
During this lecture, Sharon L. Walsh, Ph.D., will discuss how the HEALing Communities Study (HCS) is testing the prevention and treatment of opioid misuse in select communities hard hit by the opioid crisis.
-
October 27, 2022
Virtual
Joshua Denny, M.D., M.S., F.A.C.M.I., Chief Executive Officer of the National Institutes of Health’s All of Us Research Program, will discuss the program’s historic effort to collect and study data from one million or more people living in the United States.
-
September 15, 2022
Virtual
Ken Duckworth, M.D., will provide an overview of NAMI and the lessons found in his upcoming book, You Are Not Alone: The NAMI Guide to Navigating Mental Health―With Advice from Experts and Wisdom from Real Individuals and Families.
-
September 15, 2022
Virtual
In recognition of National Suicide Prevention Month in September, NIMH and the National Institute on Drug Abuse are co-hosting a Facebook Live event on the intersection of suicide and substance use.
-
June 23, 2022
Virtual
NIMH experts discussed the signs, symptoms, treatments, and latest research on the menopause transition and depression.
-
June 21, 2022
Virtual
This webinar examined the neurobiology of depression and mood disorders during the menopause transition and later life.
-
May 3, 2022
Virtual
Helen A. Neville, Ph.D., will provide an overview of the psychology of the radical healing framework.
-
February 9–10, 2022
NIMH hosted a workshop on nonaffective psychosis in midlife and beyond to share the latest findings, challenges, and opportunities for transformative research in mid to late-life populations.
-
January 12–13, 2022
The NIH Workshop on Psychedelics as Therapeutics was conducted by NIMH, the National Institute on Drug Abuse, and the National Institute on Alcohol Abuse and Alcoholism. The workshop covered the mechanistic understanding of how different psychedelic compounds act and whether perceptual and therapeutic effects might be separated.
-
September 21, 2021
This webinar provided an overview of an NIMH-sponsored study that adapts an evidence-based mental health intervention for LGBTQ+ youth of color and their families. It also showcased potential mechanisms that can be used to adapt the intervention to address mental health disparities faced by SGM youth of color.
-
August 2, 2021
NIMH’s Center for Multimodal Neuroimaging conducted a pre-recorded virtual workshop on naturalistic stimuli and individual differences.
-
January 21, 2021
This workshop provided insights into the potential challenges and opportunities for gene-based therapeutic strategies for individuals with rare genetic neurodevelopmental disorders. It brought together a multi-disciplinary group of experts from academia, government, and industry to provide a review of the current state of science in gene-targeted therapeutics and characteristics of suitable gene/molecular targets and mechanisms amenable to gene-based therapies.
-
April 2, 2020
Webinar
On April 2, the National Institute of Mental Health (NIMH) held a virtual workshop on Transforming the Practice of Mental Health Care to bring together a group of visionary thinkers to brainstorm how big data and artificial intelligence can transform care for individuals living with mental illness.
-
February 24–25, 2020
Webinar
The National Institute of Mental Health (NIMH) Division of Translational Research convened a workshop to provide a forum for NIMH-funded interdisciplinary research teams to illustrate how collaborations between basic, translational, and clinical researchers have led to the identification of novel targets for psychosocial /behavioral interventions.
-
November 13, 2018
Reddit
The National Institute of Mental Health (NIMH) and the National Institutes of Health (NIH)’s Intramural Research Program (IRP) teamed up for a Reddit “Ask Me Anything” (AMA) discussion with Dr. Carlos Zarate Jr. During the Reddit AMA, Dr. Zarate answered questions from the public about current treatments for depression and the latest research efforts to develop cutting-edge therapies for the condition.
-
July 23–24, 2018
Rockville, MD
In collaboration with SAMHSA, NIMH sponsored a workshop focused on research priorities for treatment interventions and recovery services for adults with serious mental illness (SMI).
-
May 3, 2018
On Thursday, May 3, 2018, the National Institute of Mental Health (NIMH) hosted a Twitter chat on teen depression with NIMH experts, Dr. Argyris Stringaris and Dr. Ken Towbin.
-
April 12, 2018
Webinar
NIMH IRP scientist Bruce Luber, Ph.D., conducted a webinar on depression and transcranial magnetic stimulation (TMS).
-
April 3–4, 2018
Bethesda, MD
The National Center for Complementary and Integrative Health (NCCIH) and the Office of Behavioral and Social Sciences Research (OBSSR), in collaboration NIMH and other NIH Institutes and Centers, cosponsored a roundtable discussion about research on emotional well-being.
-
November 12, 2017
Washington Convention Center, Washington, D.C.
On November 12, 2017, NIMH hosted a mini-symposium to introduce new and burgeoning field of computational psychiatry. Computational psychiatry applies cutting-edge quantitative methods and theoretical models to investigate neural or cognitive phenomena relevant to psychiatric diseases. Presentations covered practical examples of theory- and data-driven computational models of cognitive deficits associated with schizophrenia, emotion regulation, anxiety, and drug addiction.
-
November 10, 2017
Washington Marriott at Metro Center, Washington, D.C.
On November 10, 2017, NIMH convened a workshop to discuss the development of explainable artificial intelligence (XAI) solutions to guide basic and clinical interventions, and to inform our understanding of complex brain-behavioral data in the context of intelligent neuro-behavioral modulation.
-
September 19, 2017
Bethesda, MD
On September 19, 2017, NIMH hosted a workshop on challenges and opportunities for exploring rare genetic syndromes as models to delineate the genetic risk architecture of mental illnesses and to facilitate translation into meaningful prevention and treatments.